324 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 7 | next »
Genei
Gene descriptioni x
Evidencei x
Tissuei
Braini
Single celli
Subcelli
Canceri
Bloodi
Cell linei
Struct & Inti
Prognostic p-valuei x
CCL14C-C motif chemokine ligand 14
Liver Hepatocellular Carcinoma (validation): 2.21e-5
Liver Hepatocellular Carcinoma (TCGA): 7.38e-5
Stomach Adenocarcinoma (TCGA): 1.33e-4
Breast Invasive Carcinoma (validation): 1.58e-4
Lung Adenocarcinoma (TCGA): 9.89e-4
BLMHBleomycin hydrolase
Kidney Renal Clear Cell Carcinoma (TCGA): 3.72e-6
Stomach Adenocarcinoma (TCGA): 1.49e-4
Liver Hepatocellular Carcinoma (TCGA): 5.61e-4
Kidney Renal Clear Cell Carcinoma (validation): 6.22e-4
Liver Hepatocellular Carcinoma (validation): 7.87e-4
CC2D2ACoiled-coil and C2 domain containing 2A
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.22e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.32e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.33e-6
Stomach Adenocarcinoma (TCGA): 1.49e-4
BRI3BPBRI3 binding protein
Kidney Renal Clear Cell Carcinoma (TCGA): 6.24e-7
Liver Hepatocellular Carcinoma (validation): 4.94e-5
Pancreatic Adenocarcinoma (validation): 5.30e-5
Stomach Adenocarcinoma (TCGA): 1.51e-4
Liver Hepatocellular Carcinoma (TCGA): 1.98e-4
MMRN2Multimerin 2
Kidney Renal Clear Cell Carcinoma (TCGA): 9.72e-9
Liver Hepatocellular Carcinoma (validation): 7.64e-5
Stomach Adenocarcinoma (TCGA): 1.53e-4
Kidney Renal Clear Cell Carcinoma (validation): 2.22e-4
SLC22A4Solute carrier family 22 member 4
Kidney Renal Clear Cell Carcinoma (TCGA): 9.74e-9
Kidney Renal Clear Cell Carcinoma (validation): 7.46e-6
Stomach Adenocarcinoma (TCGA): 1.57e-4
Rectum Adenocarcinoma (TCGA): 6.47e-4
VWFVon Willebrand factor
Kidney Renal Clear Cell Carcinoma (TCGA): 1.46e-9
Stomach Adenocarcinoma (TCGA): 1.58e-4
Kidney Renal Clear Cell Carcinoma (validation): 7.74e-4
EPM2AEPM2A glucan phosphatase, laforin
Kidney Renal Clear Cell Carcinoma (TCGA): 4.33e-7
Kidney Renal Clear Cell Carcinoma (validation): 2.90e-5
Pancreatic Adenocarcinoma (validation): 1.42e-4
Stomach Adenocarcinoma (TCGA): 1.64e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.97e-4
Pancreatic Adenocarcinoma (TCGA): 2.46e-4
LPLLipoprotein lipase
Kidney Renal Clear Cell Carcinoma (TCGA): 2.78e-6
Kidney Renal Clear Cell Carcinoma (validation): 1.27e-4
Stomach Adenocarcinoma (TCGA): 1.79e-4
MARCKSMyristoylated alanine rich protein kinase C substrate
Liver Hepatocellular Carcinoma (TCGA): 4.01e-9
Liver Hepatocellular Carcinoma (validation): 1.00e-4
Stomach Adenocarcinoma (TCGA): 2.07e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 3.65e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 4.98e-4
FIBINFin bud initiation factor homolog
Thyroid Carcinoma (TCGA): 9.42e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.71e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 8.68e-5
Ovary Serous Cystadenocarcinoma (TCGA): 1.97e-4
Stomach Adenocarcinoma (TCGA): 2.50e-4
Pancreatic Adenocarcinoma (validation): 2.52e-4
Bladder Urothelial Carcinoma (TCGA): 4.08e-4
Ovary Serous Cystadenocarcinoma (validation): 8.02e-4
Kidney Chromophobe (TCGA): 9.17e-4
SPOCK1SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
Head and Neck Squamous Cell Carcinoma (TCGA): 2.00e-5
Lung Adenocarcinoma (TCGA): 4.07e-5
Ovary Serous Cystadenocarcinoma (validation): 2.18e-4
Stomach Adenocarcinoma (TCGA): 3.09e-4
Ovary Serous Cystadenocarcinoma (TCGA): 8.89e-4
TACC1Transforming acidic coiled-coil containing protein 1
Kidney Renal Clear Cell Carcinoma (TCGA): 6.93e-10
Kidney Renal Clear Cell Carcinoma (validation): 1.33e-6
Stomach Adenocarcinoma (TCGA): 3.36e-4
CLSPNClaspin
Lung Adenocarcinoma (TCGA): 5.94e-6
Lung Adenocarcinoma (validation): 9.04e-5
Stomach Adenocarcinoma (TCGA): 4.07e-4
LDB2LIM domain binding 2
Kidney Renal Clear Cell Carcinoma (TCGA): 2.71e-9
Skin Cuteneous Melanoma (TCGA): 2.30e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.00e-4
Liver Hepatocellular Carcinoma (validation): 4.32e-4
Stomach Adenocarcinoma (TCGA): 4.34e-4
Ovary Serous Cystadenocarcinoma (validation): 7.79e-4
MFAP3LMicrofibril associated protein 3 like
Kidney Renal Clear Cell Carcinoma (TCGA): 6.12e-9
Thyroid Carcinoma (TCGA): 3.38e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.37e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.23e-4
Stomach Adenocarcinoma (TCGA): 4.53e-4
ANGPT2Angiopoietin 2
Liver Hepatocellular Carcinoma (validation): 7.69e-5
Liver Hepatocellular Carcinoma (TCGA): 1.52e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.21e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 4.12e-4
Stomach Adenocarcinoma (TCGA): 4.65e-4
ASF1BAnti-silencing function 1B histone chaperone
Liver Hepatocellular Carcinoma (validation): 1.21e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.29e-9
Kidney Chromophobe (TCGA): 8.56e-7
Kidney Renal Clear Cell Carcinoma (validation): 1.59e-6
Pancreatic Adenocarcinoma (TCGA): 1.09e-5
Lung Adenocarcinoma (validation): 3.22e-5
Lung Adenocarcinoma (TCGA): 1.50e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 1.57e-4
Stomach Adenocarcinoma (TCGA): 4.66e-4
Liver Hepatocellular Carcinoma (TCGA): 5.76e-4
Lung Squamous Cell Carcinoma (TCGA): 9.62e-4
THRBThyroid hormone receptor beta
Kidney Renal Clear Cell Carcinoma (TCGA): 1.30e-10
Stomach Adenocarcinoma (TCGA): 4.77e-4
Kidney Renal Clear Cell Carcinoma (validation): 8.39e-4
NCLNNicalin
Liver Hepatocellular Carcinoma (validation): 4.92e-6
Liver Hepatocellular Carcinoma (TCGA): 1.39e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 2.11e-4
Stomach Adenocarcinoma (TCGA): 6.44e-4
Kidney Renal Clear Cell Carcinoma (validation): 7.33e-4
TMEM164Transmembrane protein 164
Liver Hepatocellular Carcinoma (validation): 6.60e-5
Liver Hepatocellular Carcinoma (TCGA): 1.08e-4
Stomach Adenocarcinoma (TCGA): 7.80e-4
EFNA3Ephrin A3
Liver Hepatocellular Carcinoma (TCGA): 2.89e-6
Liver Hepatocellular Carcinoma (validation): 8.57e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.81e-4
Stomach Adenocarcinoma (TCGA): 7.90e-4
LSM7LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 7.16e-5
Liver Hepatocellular Carcinoma (TCGA): 7.82e-5
Liver Hepatocellular Carcinoma (validation): 2.90e-4
Stomach Adenocarcinoma (TCGA): 8.45e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 9.88e-4
AHCYL2Adenosylhomocysteinase like 2
Pancreatic Adenocarcinoma (validation): 3.49e-4
Kidney Renal Clear Cell Carcinoma (validation): 4.08e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.59e-4
Stomach Adenocarcinoma (TCGA): 8.67e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 9.59e-4
MXD3MAX dimerization protein 3
Kidney Renal Clear Cell Carcinoma (TCGA): 1.28e-13
Kidney Renal Clear Cell Carcinoma (validation): 1.13e-7
Liver Hepatocellular Carcinoma (TCGA): 1.04e-5
Stomach Adenocarcinoma (TCGA): 8.93e-4
FBXO17F-box protein 17
Glioblastoma Multiforme (validation): 2.93e-7
Lung Adenocarcinoma (TCGA): 6.99e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 5.77e-4
Glioblastoma Multiforme (TCGA): 7.09e-4
Stomach Adenocarcinoma (TCGA): 9.02e-4
TCN2Transcobalamin 2
Kidney Renal Clear Cell Carcinoma (TCGA): 3.08e-7
Kidney Renal Clear Cell Carcinoma (validation): 6.36e-5
Liver Hepatocellular Carcinoma (TCGA): 7.62e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.57e-4
Stomach Adenocarcinoma (TCGA): 9.20e-4
SERPINE1Serpin family E member 1
Stomach Adenocarcinoma (TCGA): 7.70e-7
Lung Squamous Cell Carcinoma (validation): 7.57e-6
Head and Neck Squamous Cell Carcinoma (TCGA): 4.09e-5
Lung Squamous Cell Carcinoma (TCGA): 1.32e-4
Glioblastoma Multiforme (validation): 1.69e-4
Lung Adenocarcinoma (TCGA): 3.17e-4
Pancreatic Adenocarcinoma (TCGA): 5.82e-4
RNF144ARing finger protein 144A
Stomach Adenocarcinoma (TCGA): 1.47e-6
Kidney Chromophobe (TCGA): 1.59e-4
Liver Hepatocellular Carcinoma (TCGA): 1.73e-4
AKR1B1Aldo-keto reductase family 1 member B
Stomach Adenocarcinoma (TCGA): 2.51e-6
Glioblastoma Multiforme (TCGA): 1.70e-5
SLC52A3Solute carrier family 52 member 3
Stomach Adenocarcinoma (TCGA): 4.17e-6
Uterine Corpus Endometrial Carcinoma (TCGA): 6.74e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.22e-5
Pancreatic Adenocarcinoma (TCGA): 5.25e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 9.34e-4
GPR176G protein-coupled receptor 176
Stomach Adenocarcinoma (TCGA): 4.21e-6
Lung Adenocarcinoma (validation): 7.19e-5
Lung Adenocarcinoma (TCGA): 4.59e-4
MISP3MISP family member 3
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.65e-6
Stomach Adenocarcinoma (TCGA): 7.36e-6
Pancreatic Adenocarcinoma (validation): 2.03e-4
GJA1Gap junction protein alpha 1
Stomach Adenocarcinoma (TCGA): 9.96e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 3.21e-5
Glioblastoma Multiforme (validation): 3.44e-4
DUSP1Dual specificity phosphatase 1
Stomach Adenocarcinoma (TCGA): 1.22e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 4.69e-4
PHYHIPPhytanoyl-CoA 2-hydroxylase interacting protein
Stomach Adenocarcinoma (TCGA): 1.29e-5
Breast Invasive Carcinoma (validation): 3.77e-4
RAB31RAB31, member RAS oncogene family
Stomach Adenocarcinoma (TCGA): 1.31e-5
PIP4P2Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2
Stomach Adenocarcinoma (TCGA): 1.41e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.59e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 2.80e-4
Ovary Serous Cystadenocarcinoma (validation): 5.17e-4
Liver Hepatocellular Carcinoma (TCGA): 8.75e-4
MAGED4BMAGE family member D4B
Stomach Adenocarcinoma (TCGA): 1.68e-5
Kidney Renal Clear Cell Carcinoma (validation): 2.22e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 8.71e-5
Pancreatic Adenocarcinoma (TCGA): 8.69e-4
SRPX2Sushi repeat containing protein X-linked 2
Kidney Renal Clear Cell Carcinoma (TCGA): 4.52e-8
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.78e-7
Stomach Adenocarcinoma (TCGA): 3.05e-5
Rectum Adenocarcinoma (validation): 8.95e-5
Lung Squamous Cell Carcinoma (validation): 8.30e-4
RAMP1Receptor activity modifying protein 1
Stomach Adenocarcinoma (TCGA): 3.22e-5
Liver Hepatocellular Carcinoma (TCGA): 8.13e-4
MATN3Matrilin 3
Stomach Adenocarcinoma (TCGA): 3.26e-5
Ovary Serous Cystadenocarcinoma (validation): 3.59e-5
Liver Hepatocellular Carcinoma (TCGA): 6.84e-5
ENSG00000285218Novel protein
Stomach Adenocarcinoma (TCGA): 3.56e-5
CPNE8Copine 8
Glioblastoma Multiforme (validation): 8.03e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 2.30e-5
Stomach Adenocarcinoma (TCGA): 4.00e-5
Uterine Corpus Endometrial Carcinoma (TCGA): 4.62e-4
Lung Adenocarcinoma (validation): 6.13e-4
LANCL2LanC like glutathione S-transferase 2
Kidney Renal Clear Cell Carcinoma (TCGA): 9.69e-6
Stomach Adenocarcinoma (TCGA): 4.31e-5
Pancreatic Adenocarcinoma (TCGA): 9.33e-5
Kidney Renal Clear Cell Carcinoma (validation): 2.68e-4
ITGAVIntegrin subunit alpha V
Kidney Renal Clear Cell Carcinoma (TCGA): 9.16e-9
Stomach Adenocarcinoma (TCGA): 4.51e-5
Lung Adenocarcinoma (validation): 7.00e-5
Liver Hepatocellular Carcinoma (TCGA): 3.07e-4
Lung Adenocarcinoma (TCGA): 6.38e-4
GSDMEGasdermin E
Liver Hepatocellular Carcinoma (TCGA): 1.83e-5
Stomach Adenocarcinoma (TCGA): 4.87e-5
Uterine Corpus Endometrial Carcinoma (TCGA): 4.95e-5
CGB5Chorionic gonadotropin subunit beta 5
Stomach Adenocarcinoma (TCGA): 4.90e-5
Pancreatic Adenocarcinoma (TCGA): 7.09e-4
VCANVersican
Ovary Serous Cystadenocarcinoma (validation): 1.13e-6
Stomach Adenocarcinoma (TCGA): 5.20e-5
Page of 7 | next »